
AI is about to change healthcare. These 34 stocks are working on everything from early diagnostics to drug discovery. The best part - they are all under $10b in market cap - there's still time to get in early.
For SEALSQ to make sense in a portfolio, you really have to believe in its attempt to sit at the heart of quantum‑safe security for IoT, smart energy and critical infrastructure, rather than in its current financial profile. The latest quarter’s roughly US$4.1 million in preliminary revenue, versus US$1.3 million a year earlier, suggests that demand is starting to catch up with the company’s ambitious product roadmap, while the progress toward Common Criteria and FIPS certifications strengthens the case that its chips can meet the bar for regulated and government buyers. That said, the stock has sold off sharply in recent months despite this news, which keeps the key short term catalysts and risks in sharp focus: turning pipeline into repeat orders, managing heavy losses and dilution, and actually monetizing high profile partnerships like the planned India PQC personalization center.
However, investors should also be aware of the ongoing dilution and widening net losses. According our valuation report, there's an indication that SEALSQ's share price might be on the expensive side.Explore 19 other fair value estimates on SEALSQ - why the stock might be worth over 7x more than the current price!
Disagree with this assessment? Extraordinary investment returns rarely come from following the herd, so go with your instincts.
Our daily scans reveal stocks with breakout potential. Don't miss this chance:
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com